Comment
doi: 10.1016/S0140-6736(16)31410-6.
Epub 2016 Aug 30.
Do NOACs ENSURE safe cardioversion in atrial fibrillation?
Affiliations
- PMID: 27590222
- DOI: 10.1016/S0140-6736(16)31410-6
Item in Clipboard
Comment
Do NOACs ENSURE safe cardioversion in atrial fibrillation?
Lancet.
.
No abstract available
Comment on
-
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.Lancet. 2016 Oct 22;388(10055):1995-2003. doi: 10.1016/S0140-6736(16)31474-X. Epub 2016 Aug 30. Lancet. 2016. PMID: 27590218 Clinical Trial.
Similar articles
-
Novel oral anticoagulants in patients undergoing cardioversion for atrial fibrillation.J Thromb Thrombolysis. 2015 Aug;40(2):139-43. doi: 10.1007/s11239-014-1161-7. J Thromb Thrombolysis. 2015. PMID: 25542262 Review.
-
[Cardioversion of atrial fibrillation].Ugeskr Laeger. 2013 Oct 21;175(43):2549-53. Ugeskr Laeger. 2013. PMID: 24629150 Review. Danish.
-
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study.Am Heart J. 2015 May;169(5):597-604.e5. doi: 10.1016/j.ahj.2015.02.009. Epub 2015 Feb 21. Am Heart J. 2015. PMID: 25965706 Clinical Trial.
-
Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation.Heart Lung Circ. 2018 Jul;27(7):798-803. doi: 10.1016/j.hlc.2017.06.726. Epub 2017 Jul 17. Heart Lung Circ. 2018. PMID: 28802808
-
Quick, easy, and safe? On the use of low-molecular-weight heparins in cardioversion of atrial fibrillation.Eur Heart J. 2006 Dec;27(23):2742-3. doi: 10.1093/eurheartj/ehl350. Epub 2006 Nov 10. Eur Heart J. 2006. PMID: 17098755 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
